GlobeNewswire

Milestone Pharmaceuticals to Announce Third Quarter 2026 Financial Results on November 13, 2026
03/11/2026
MONTREAL and CHARLOTTE, N.C., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Milestone ® Pharmaceuticals Inc. (Nasdaq: MIST), a biopharmaceutical company focused on the development and commercialization of innovative cardiovascular [...]
Phathom Pharmaceuticals Announces Eligible Commercially Insured Patients May Now Pay as Little as $0 for VOQUEZNA® (vonoprazan) Tablets Exclusively at BlinkRx
03/11/2026
Potential to pay as little as $0 per fill for VOQUEZNA, plus free home delivery and prior authorization support, makes it simpler for GERD patients to get the medicine their doctor prescribed A Media Snippet [...]
Allogene Highlights Clinical Progress and Next-Generation Innovation Across Its Off-the-Shelf CAR T Platform at SITC Annual Meeting
03/11/2026
Two Invited Presentations Showcase Clinical Progress in Solid Tumors and Allogene's Broader Vision in Oncology and Autoimmune Disease Preclinical Poster Features Next-Generation DLL3/CD70 Dual CAR T Product Candidate [...]
Children’s Healthcare Canada releases Start Strong, a National Playbook to Transform Child and Youth Health Systems
03/11/2026
Start Strong sets out a vision for federal, provincial, and territorial governments to deliver better, more equitable healthcare to Canada's 8.6 million children OTTAWA, Ontario, Nov. 03, 2026 (GLOBE NEWSWIRE) -- [...]
Santé des enfants Canada publie Le meilleur départ, une feuille de route nationale pour transformer les systèmes de santé des enfants et des jeunes
03/11/2026
Le meilleur départ présente une vision à l’intention des gouvernements fédéral, provinciaux et territoriaux pour améliorer la qualité et l’équité des soins de santé aux 8,6 millions d’enfants au Canada OTTAWA, Ontario, [...]
LENSAR® to Report Third Quarter 2026 Results on November 10th, 2026
03/11/2026
ORLANDO, Fla., Nov. 03, 2026 (GLOBE NEWSWIRE) -- LENSAR, Inc. (Nasdaq: LNSR) (“LENSAR” or the “Company”), a global medical technology company focused on advanced robotic laser solutions for the treatment of cataracts, [...]
4DMT to Participate in Upcoming Investor Conferences
03/11/2026
EMERYVILLE, Calif., Nov. 03, 2026 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with [...]
Bolt Biotherapeutics to Participate in Upcoming Conferences
03/11/2026
REDWOOD CITY, Calif., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Bolt Biotherapeutics, Inc. (Nasdaq: BOLT) (“Bolt” or the “Company”), a clinical-stage biotechnology company pioneering a new generation of half-life-extended [...]
Avalyn to Present at Upcoming Investor Conferences
03/11/2026
BOSTON, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc. (Nasdaq: AVLN), a clinical-stage biopharmaceutical company pioneering inhaled therapies to transform the treatment paradigm of serious, rare respiratory [...]
Cabaletta Bio to Participate in Upcoming Investor Conferences
03/11/2026
PHILADELPHIA, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Cabaletta Bio, Inc. (Nasdaq: CABA), a late-stage clinical biotechnology company focused on developing and launching curative targeted cell therapies designed specifically [...]
Humacyte Innovative Research in Coronary Bypass and Vascular Regeneration to be Highlighted at American Heart Association Scientific Sessions 2026
03/11/2026
– Founder & CEO Laura Niklason, M.D., Ph.D., to deliver invited talk on engineering the microenvironment to accelerate vascular regeneration. – Two additional presentations to cover first-in-human Phase 2a study [...]
Geron Corporation to Participate in the Stifel 2026 Healthcare Conference
03/11/2026
FOSTER CITY, Calif., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Geron Corporation (Nasdaq: GERN), a hematology-focused biopharmaceutical company pursuing more meaningful moments for people living with blood cancer, today [...]
City Therapeutics to Present at Upcoming November Investor Conferences
03/11/2026
CAMBRIDGE, Mass., Nov. 03, 2026 (GLOBE NEWSWIRE) -- City Therapeutics, Inc. (Nasdaq: CTY), a clinical-stage biotechnology company developing the next generation of RNA interference (RNAi) therapeutics, today announced [...]
Relmada Therapeutics to Report Third Quarter 2026 Financial Results on Thursday, November 12, 2026
03/11/2026
CORAL GABLES, Fla., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Relmada Therapeutics, Inc. (Nasdaq: RLMD, “Relmada” or the “Company”), a clinical-stage biotechnology company advancing innovative therapies for oncology and central [...]
Madrigal Pharmaceuticals Reports Third-Quarter 2026 Financial Results and Provides Corporate Updates
03/11/2026
Third-quarter 2026 Rezdiffra ® (resmetirom) net sales of $431.3 million, representing year-over-year growth of 50%; achieved first quarter of profitability Rezdiffra reaches a major milestone, achieving blockbuster [...]
C4 Therapeutics to Participate in Upcoming November Investor Conferences
03/11/2026
WATERTOWN, Mass., Nov. 03, 2026 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation (TPD) science, today [...]
Rhythm Pharmaceuticals Reports Third Quarter 2026 Financial Results and Business Update
03/11/2026
-- Strong U.S. launch momentum for IMCIVREE ® (setmelanotide) for acquired hypothalamic obesity (HO) continues with more than 700 patient start forms as of September 30, 2026 -- -- Third quarter 2026 net product revenue [...]
Arvinas Reports Third Quarter 2026 Financial Results and Provides Corporate Update
03/11/2026
– Initiated dosing in a Phase 1/2 trial of ARV-6723, an immuno-oncology oral PROTAC designed to degrade HPK1, a negative regulator of immune activation – – Reaffirmed commitment to share clinical data from three Phase 1 [...]
Oruka Therapeutics to Participate in Multiple Upcoming Conferences
03/11/2026
MENLO PARK, Calif., Nov. 03, 2026 (GLOBE NEWSWIRE) -- Oruka Therapeutics, Inc. (“Oruka”) (Nasdaq: ORKA), a clinical-stage biotechnology company developing novel biologics designed to set a new standard for the treatment [...]

Pages

Other news

Test 2

Lorem ipsum

Test 1

Lorem upsum